Racura Oncology cleared to double RC220 trial dosage
Racura Oncology (ASX:RAC) announced a milestone in its Phase 1 CPACS clinical trial, receiving formal clearance to escalate the dosage of its lead candidate, RC220.
Racura Oncology (ASX:RAC) announced a milestone in its Phase 1 CPACS clinical trial, receiving formal clearance to escalate the dosage of its lead candidate, RC220.
Oobit launched its crypto payments platform in Colombia, expanding the Tether-backed company’s operations across Latin America.
Dartmouth College disclosed approximately $14.5 million in cryptocurrency-related ETF holdings, expanding the digital asset exposure of its $9 billion endowment portfolio.
Vicinity Centres (ASX:VCX) exchanged contracts with Frasers Property to acquire the Eastern Creek Quarter in Western Sydney for $400 million.
Forward Industries reported a $585.6 million fiscal first-quarter loss after declines in Solana prices triggered large accounting-related write-downs on its crypto holdings.
Prestal (ASX:PTL) announced the divestment of its core undertaking, Hampers with Bite, to Gourmet Brands Two.
Bitcoin rose above $82,000 on Thursday after the US Senate Banking Committee advanced the CLARITY Act, boosting investor optimism around clearer cryptocurrency regulation in the United States.
Resolution Minerals (ASX:RML) launched its 2026 drilling campaign at the Golden Gate Project.
Sydney-based xReality Group (ASX:XRG) completed a high-stakes, 20-month subcontract for the US Department of Defence.
HashKey Exchange listed Hyperliquid’s native HYPE token for trading, expanding access to the fast-growing altcoin on one of Hong Kong’s largest licensed cryptocurrency platforms.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
